All PI3Kinase signaling is not mTOR: Dissecting mtor-dependent and independent signaling pathways in T cells

Frontiers in Immunology

Volumn 3, Issue OCT, 2012, Pages

  Gamper, Christopher J ^a   Powell, Jonathan D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

CD4 T cells; Effector function; Mtor pathway; Pi3k; Tolerance

Indexed keywords

EID: 84871483253     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00312     Document Type: Review

References (72)

1. Alcazar, I., Marques, M., Kumar, A., Hirsch, E., Wymann, M., Carrera, A. C., et al. (2007). Phosphoinositide 3-kinase gamma participates in T cell receptor-induced T cell activation. J. Exp. Med. 204, 2977-2987.
2. Battaglia, M., Stabilini, A., and Roncarolo, M. G. (2005). Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105, 4743-4748.
3. Bensinger, S. J., Walsh, P. T., Zhang, J., Carroll, M., Parsons, R., Rathmell, J. C., et al. (2004). Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J. Immunol. 172, 5287-5296.
4. Brownawell, A. M., Kops, G. J., Macara, I. G., and Burgering, B. M. (2001). Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol. Cell. Biol. 21, 3534-3546.
5. Brunn, G. J., Williams, J., Sabers, C., Wiederrecht, G., Lawrence, J. C. Jr., and Abraham, R. T. (1996). Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinosi-tide 3-kinase inhibitors, wortman-nin and LY294002. EMBO J. 15, 5256-5267.
6. Cantrell, D. (2002). Protein kinase B (Akt) regulation and function in T lymphocytes. Semin. Immunol. 14, 19-26.
7. Cantrell, D.A. (2001). Phosphoinositide 3-kinase signalling pathways. J. Cell Sci. 114, 1439-1445.
8. Clayton, E., Bardi, G., Bell, S. E., Chantry, D., Downes, C. P., Gray, A., et al. (2002). A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J. Exp. Med. 196, 753-763.
9. Coffer, P. J., and Burgering, B. M. (2004). Forkhead-box transcription factors and their role in the immune system. Nat. Rev. Immunol. 4, 889-899.
10. Crotty, S. (2011). Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29, 621-663.
11. Currie, R. A., Walker, K. S., Gray, A., Deak, M., Casamayor, A., Downes, C. P., et al. (1999). Role of phosphatidylinositol 3 4, 5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1. Biochem. J. 337(Pt 3), 575-583.
12. Dang, E. V., Barbi, J., Yang, H. Y., Jinasena, D., Yu, H., Zheng, Y., et al. (2011). Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146, 772-784.
13. Deane, J. A., Kharas, M. G., Oak, J. S., Stiles, L. N., Luo, J., Moore, T. I., et al. (2007). T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling. Blood 109, 2894-2902.
14. Deane, J. A., Trifilo, M. J., Yballe, C. M., Choi, S., Lane, T. E., and Fruman, D. A. (2004). Enhanced T cell proliferation in mice lacking the p85beta subunit of phospho-inositide 3-kinase. J. Immunol. 172, 6615-6625.
15. Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., et al. (2009). The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30, 832-844.
16. Delgoffe, G. M., Pollizzi, K. N., Waickman, A. T., Heikamp, E., Meyers, D. J., Horton, M. R., et al. (2011). The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 12, 295-303.
17. Facchinetti, V., Ouyang, W., Wei, H., Soto, N., Lazorchak, A., Gould, C., et al. (2008). The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J. 27, 1932-1943.
18. Finlay, D., and Cantrell, D. (2010). Phosphoinositide 3-kinase and the mammalian target of rapamycin pathways control T cell migration. Ann. N.Y. Acad. Sci. 1183, 149-157.
19. Fruman, D. A., Snapper, S. B., Yballe, C. M., Davidson, L., Yu, J. Y., Alt, F. W., et al. (1999). Impaired B cell development and prolifera tion in absence of phosphoinosi- tide 3-kinase p85alpha. Science 283, 393-397.
20. Garcia-Martinez, J. M., and Alessi, D. R. (2008). mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activa tion of serum- and glucocorticoid- induced protein kinase 1 (SGK1). Biochem. J. 416, 375-385.
21. Garcon, F., Patton, D. T., Emery, J. L., Hirsch, E., Rottapel, R., Sasaki, T., et al. (2008). CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer. Blood 111, 1464-1471.
22. Glidden, E. J., Gray, L. G., Vemuru, S., Li, D., Harris, T. E., and Mayo, M. W. (2012). Multiple site acetylation of Rictor stimulates mammalian target of rapamycin complex 2 (mTORC2)-dependent phosphory-lation of Akt protein. J. Biol. Chem. 287, 581-588.
23. Haylock-Jacobs, S., Comerford, I., Bunting, M., Kara, E., Townley, S., Klingler-Hoffmann, M., et al. (2011). PI3Kdelta drives the pathogenesis of experimental autoimmune encephalomyeli-tis by inhibiting effector T cell apoptosis and promoting Th17 differentiation. J. Autoimmun. 36, 278-287.
24. Hsieh, M. M., Kang, E. M., Fitzhugh, C. D., Link, M. B., Bolan, C. D., Kurlander, R., et al. (2009). Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N. Engl. J. Med. 361, 2309-2317.
25. Jacinto, E., Facchinetti, V., Liu, D., Soto, N., Wei, S., Jung, S. Y., et al. (2006). SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127, 125-137.
26. Kane, L. P., and Weiss, A. (2003). The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3. Immunol. Rev. 192, 7-20.
27. Kang, J., Huddleston, S. J., Fraser, J. M., and Khoruts, A. (2008). De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR. J. Leukoc. Biol. 83, 1230-1239.
28. Kay, J. E., Kromwel, L., Doe, S. E., and Denyer, M. (1991). Inhibition of T and B lymphocyte proliferation by rapamycin. Immunology 72, 544-549.
29. Kurebayashi, Y., Nagai, S., Ikejiri, A., Ohtani, M., Ichiyama, K., Baba, Y., et al. (2012). PI3K-Akt-mTORC1-S6K1/2 Axis Controls Th17 Differentiation by Regulating Gfi1 Expression and Nuclear Translocation of RORgamma. Cell Rep. 1, 360-373.
30. Laplante, M., and Sabatini, D. M. (2012). mTOR signaling in growth control and disease. Cell 149, 274-293.
31. Lee, K., Gudapati, P., Dragovic, S., Spencer, C., Joyce, S., Killeen, N., et al. (2010). Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity 32, 743-753.
32. Liu, D., Zhang, T., Marshall, A. J., Okkenhaug, K., Vanhaesebroeck, B., and Uzonna, J. E. (2009). The p110delta isoform of phosphatidyli-nositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells. J. Immunol. 183, 1921-1933.
33. Macian, F., Garcia-Cozar, F., Im, S. H., Horton, H. F., Byrne, M. C., and Rao, A. (2002). Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109, 719-731.
34. Marshall, N. A., Galvin, K. C., Corcoran, A. M., Boon, L., Higgs, R., and Mills, K. H. (2012). Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-gamma+IL-17+ polyfunctional T cells that mediate rejection of murine tumors. Cancer Res. 72, 581-591.
35. Martin, A. L., Schwartz, M. D., Jameson, S. C., and Shimizu, Y. (2008). Selective regulation of CD8 effector T cell migration by the p110 gamma isoform of phosphatidyli-nositol 3-kinase. J. Immunol. 180, 2081-2088.
36. Milburn, C. C., Deak, M., Kelly, S. M., Price, N. C., Alessi, D. R., and Van Aalten, D. M. (2003). Binding of phosphatidylinositol 3 4, 5-trisphosphate to the pleck-strin homology domain of protein kinase B induces a confor-mational change. Biochem. J. 375, 531-538.
37. Nashed, B. F., Zhang, T., Al-Alwan, M., Srinivasan, G., Halayko, A. J., Okkenhaug, K., et al. (2007). Role of the phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation. Eur. J. Immunol. 37, 416-424.
38. Oak, J. S., Deane, J. A., Kharas, M. G., Luo, J., Lane, T. E., Cantley, L. C., et al. (2006). Sjogren's syndromelike disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Proc. Natl. Acad. Sci. U.S.A. 103, 16882-16887.
39. Okkenhaug, K., Bilancio, A., Farjot, G., Priddle, H., Sancho, S., Peskett, E., et al. (2002). Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science 297, 1031-1034.
40. Okkenhaug, K., and Fruman, D. A. (2010). PI3Ks in lymphocyte signaling and development. Curr. Top. Microbiol. Immunol. 346, 57-85.
41. Okkenhaug, K., Patton, D. T., Bilancio, A., Garcon, F., Rowan, W. C., and Vanhaesebroeck, B. (2006). The p110delta isoform of phosphoinosi-tide 3-kinase controls clonal expansion and differentiation of Th cells. J. Immunol. 177, 5122-5128.
42. Okkenhaug, K., and Vanhaesebroeck, B. (2003). PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 3, 317-330.
43. Ouyang, W., Beckett, O., Ma, Q., Paik, J. H., Depinho, R. A., and Li, M. O. (2010). Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat. Immunol. 11, 618-627.
44. Patton, D. T., Garden, O. A., Pearce, W. P., Clough, L. E., Monk, C. R., Leung, E., et al. (2006). Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells. J. Immunol. 177, 6598-6602.
45. Powell, J. D., Fitzhugh, C., Kang, E. M., Hsieh, M., Schwartz, R. H., and Tisdale, J. F. (2005). Low-dose radiation plus rapamycin promotes long-term bone marrow chimerism. Transplantation 80, 1541-1545.
46. Powell, J. D., Lerner, C. G., and Schwartz, R. H. (1999). Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. J. Immunol. 162, 2775-2784.
47. Rolf, J., Bell, S. E., Kovesdi, D., Janas, M. L., Soond, D. R., Webb, L. M., et al. (2010). Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction. J. Immunol. 185, 4042-4052.
48. Safford, M., Collins, S., Lutz, M. A., Allen, A., Huang, C. T., Kowalski, J., et al. (2005). Egr-2 and Egr-3 are negative regulators of T cell activation. Nat. Immunol. 6, 472-480.
49. Salmond, R. J., Emery, J., Okkenhaug, K., and Zamoyska, R. (2009). MAPK, phosphatidylinositol 3-kinase, and mammalian target of rapamycin pathways converge at the level of ribosomal protein S6 phosphorylation to control metabolic signaling in CD8 T cells. J. Immunol. 183, 7388-7397.
50. Sanjuan, M. A., Jones, D. R., Izquierdo, M., and Merida, I. (2001). Role of diacylglycerol kinase alpha in the attenuation of receptor signaling. J. Cell Biol. 153, 207-220.
51. Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J. H., Hsu, P. P., Bagley, A. F., et al. (2006). Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22, 159-168.
52. Sarbassov, D. D., Guertin, D. A., Ali, S. M., and Sabatini, D. M. (2005). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101.
53. Sasaki, T., Irie-Sasaki, J., Jones, R. G., Oliveira-Dos-Santos, A. J., Stanford, W. L., Bolon, B., et al. (2000). Function of PI3Kgamma in thymo-cyte development, T cell activation, and neutrophil migration. Science 287, 1040-1046.
54. Sauer, S., Bruno, L., Hertweck, A., Finlay, D., Leleu, M., Spivakov, M., et al. (2008). T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. U.S.A. 105, 7797-7802.
55. Schmidt-Supprian, M., Tian, J., Grant, E. P., Pasparakis, M., Maehr, R., Ovaa, H., et al. (2004). Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc. Natl. Acad. Sci. U.S.A. 101, 4566-4571.
56. So, L., and Fruman, D. A. (2012). PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances. Biochem. J. 442, 465-481.
57. Soond, D. R., Bjorgo, E., Moltu, K., Dale, V. Q., Patton, D. T., Torgersen, K. M., et al. (2010). PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans. Blood 115, 2203-2213.
58. Soond, D. R., Garcon, F., Patton, D. T., Rolf, J., Turner, M., Scudamore, C., et al. (2012). Pten loss in CD4 T cells enhances their helper function but does not lead to autoimmu-nity or lymphoma. J. Immunol. 188, 5935-5943.
59. Stokoe, D., Stephens, L. R., Copeland, T., Gaffney, P. R., Reese, C. B., Painter, G. F., et al. (1997). Dual role of phosphatidylinositol-3 4, 5-trisphosphate in the activation of protein kinase B. Science 277, 567-570.
60. Suzuki, A., Yamaguchi, M. T., Ohteki, T., Sasaki, T., Kaisho, T., Kimura, Y., et al. (2001). T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14, 523-534.
61. Suzuki, H., Terauchi, Y., Fujiwara, M., Aizawa, S., Yazaki, Y., Kadowaki, T., et al. (1999). Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phos-phoinositide 3-kinase. Science 283, 390-392.
62. Taub, D. D., Murphy, W. J., Asai, O., Fenton, R. G., Peltz, G., Key, M. L., et al. (1997). Induction of alloantigen-specific T cell tolerance through the treatment of human T lymphocytes with wortmannin. J. Immunol. 158, 2745-2755.
63. Thomas, M. S., Mitchell, J. S., Denucci, C. C., Martin, A. L., and Shimizu, Y. (2008). The p110gamma isoform of phosphatidylinositol 3-kinase regulates migration of effector CD4 T lymphocytes into peripheral inflammatory sites. J. Leukoc. Biol. 84, 814-823.
64. Waickman, A. T., and Powell, J. D. (2012). Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells. J. Immunol. 188, 4721-4729.
65. Walsh, P. T., Buckler, J. L., Zhang, J., Gelman, A. E., Dalton, N. M., Taylor, D. K., et al. (2006). PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tr e g s. J. Clin. Invest. 116, 2521-2531.
66. Ward, S. G., Wilson, A., Turner, L., Westwick, J., and Sansom, D. M. (1995). Inhibition of CD28-mediated T cell costimulation by the phosphoinositide 3-kinase inhibitor wortmannin. Eur. J. Immunol. 25, 526-532.
67. Weaver, C. T., Harrington, L. E., Mangan, P. R., Gavrieli, M., and Murphy, K. M. (2006). Th17, an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24, 677-688.
68. Wensky, A. K., Furtado, G. C., Marcondes, M. C., Chen, S., Manfra, D., Lira, S. A., et al. (2005). IFN-gamma determines distinct clinical outcomes in autoimmune encephalomyelitis. J. Immunol. 174, 1416-1423.
69. Ying, H., Fu, H., Rose, M. L., McCormack, A. M., Sarathchandra, P., Okkenhaug, K., et al. (2012). Genetic or pharmaceutical blockade of phosphoinositide 3-kinase p110delta prevents chronic rejection of heart allo-grafts. PLoS ONE 7:e32892. doi: 10.1371/journal.pone.0032892
70. Zha, Y., Marks, R., Ho, A. W., Peterson, A. C., Janardhan, S., Brown, I., et al. (2006). T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-alpha. Nat. Immunol. 7, 1166-1173.
71. Zheng, Y., Delgoffe, G. M., Meyer, C. F., Chan, W., and Powell, J. D. (2009). Anergic T cells are metabolically anergic. J. Immunol. 183, 6095-6101
72. Zinzalla, V., Stracka, D., Oppliger, W., and Hall, M. N. (2011). Activation of mTORC2 by association with the ribosome. Cell 144, 757-768.